Cognitive, Psychological, and Physical Functioning in Long-COVID Patients With Different Levels of Fatigue.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-05-05

Study Completion Date

2024-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Post COVID-19 usually occurs 3 months from the onset of COVID-19 with symptoms that last for at least 2 months and cannot be explained by an alternative diagnosis. Patients report a range of disabling symptoms such as fatigue, shortness of breath, cognitive impairment, memory loss and mental health and employment issues. This clinical heterogeneity complicates the identification of the appropriate needs and care.

The aim of this cross-sectional study is to identify subgroups (clusters) of post COVID patients based on clinical symptoms, demographic characteristics, levels of fatigue and physical, cognitive and psychological functioning of the individuals.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Neuropsychological Sequelae and Long COVID-19 Fatigue

NCT05323318

Anxiety Depression Post Traumatic Stress Disorder Mental Fatigue +2 more

UNKNOWN

Depressive Symptoms, Cognitive Impairment, and Outcomes in Hospitalized Chronic Heart Failure Patients

NCT07284446

Congestive Heart Failure Chronic Cognitive Impairment, Mild Depressive Symptoms Mild to Moderate in Severity

RECRUITING

"Long COVID-19" on the Human Brain

NCT05433324

COVID-19 Long Covid Post Acute Sequelae of COVID-19

COMPLETED

Cardiac Markers in Depressed Patients With Coronary Heart Disease - R01HL147862

NCT04682769

Coronary Heart Disease Depression

COMPLETED

Cognitive Markers of Response to Treatment in Resistant Depression

NCT02774980

Depression

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post-Acute COVID-19 Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

The participant must report current persisting symptoms (such as brain fog, anxiety, shortness of breath, headaches but also others) and indicate on the Post COVID-19 Functional Status Scale that these have an impact on everyday functioning (grade 2, 3, and 4). These symptoms need to be present for more than two months.

* Fatigue Severity Scale (FSS) score \> 4
* Aged over 18 years old
* Willing to sign the digital informed consent
* Dutch speaking and Dutch understanding
* Be tested positive for COVID-19, i.e. by reverse transcription polymerase chain reaction (RT-PCR), computed tomography (CT) of the lungs, or symptom-based diagnosis by the general practitioner.